UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial

Journal of clinical oncology, 2013-09, Vol.31 (25), p.3110-3118

2013

Volltextzugriff (PDF)

Long-Term Prognosis of Acute Myeloid Leukemia According to the New Genetic Risk Classification of the European LeukemiaNet Recommendations: Evaluation of the Proposed Reporting System

Journal of clinical oncology, 2011-07, Vol.29 (20), p.2758-2765

2011

Volltextzugriff (PDF)

Prophylactic Platelet Transfusion

The New England journal of medicine, 2013-08, Vol.369 (6), p.577-578

2013

Volltextzugriff (PDF)

WHO classification of myeloid neoplasms and leukemia

Blood, 2010-01, Vol.115 (3), p.748-749

2010

Volltextzugriff (PDF)

Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Hematologic Malignancies After Dose-Escalated Treosulfan/Fludarabine Conditioning

Journal of clinical oncology, 2010-07, Vol.28 (20), p.3344-3351

2010

Volltextzugriff (PDF)

Phase III Trial of High-Dose Sequential Chemotherapy With Peripheral Blood Stem Cell Support Compared With Standard Dose Chemotherapy for First-Line Treatment of Advanced Ovarian Cancer: Intergroup Trial of the AGO-Ovar/AIO and EBMT

Journal of clinical oncology, 2007-09, Vol.25 (27), p.4187-4193

2007

Volltextzugriff (PDF)

In Reply

Deutsches Ärzteblatt international, 2015-07

2015

Volltextzugriff (PDF)

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

The New England journal of medicine, 2014-05, Vol.370 (19), p.1781-1789

2014

Volltextzugriff (PDF)

Platelet Transfusion in Hematology, Oncology and Surgery

Deutsches Ärzteblatt international, 2014-11

2014

Volltextzugriff (PDF)

Cytarabine Dose of 36 g/m2 Compared With 12 g/m2 Within First Consolidation in Acute Myeloid Leukemia: Results of Patients Enrolled Onto the Prospective Randomized AML96 Study

Journal of clinical oncology, 2011-07, Vol.29 (19), p.2696-2702

2011

Volltextzugriff (PDF)

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Blood, 2008-01, Vol.111 (2), p.558-565

2008

Volltextzugriff (PDF)

Therapeutic platelet transfusion for hypoproliferative thrombocytopenia – Authors' reply

The Lancet (British edition), 2013-03, Vol.381 (9868), p.724-724

2013

Volltextzugriff (PDF)

Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)

Blood, 2006-12, Vol.108 (13), p.4003-4008

2006

Volltextzugriff (PDF)

Platelet transfusion in hematology, oncology and surgery

Deutsches Ärzteblatt international, 2014-11, Vol.111 (48), p.809-815

2014

Volltextzugriff (PDF)

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

Blood, 2004-11, Vol.104 (10), p.3064-3071

2004

Volltextzugriff (PDF)

A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

Blood, 2010-08, Vol.116 (6), p.971-978

2010

Volltextzugriff (PDF)

Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)

Bone marrow transplantation (Basingstoke), 2003-06, Vol.31 (11), p.973-979

2003

Volltextzugriff (PDF)

Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas : Results of a prospective randomized trial of the german low-grade lymphoma study group

Cancer, 2006-09, Vol.107 (5), p.1014-1022

2006

Volltextzugriff (PDF)

Consolidation Therapy Is Associated with Significantly Lower Bleeding Risk Compared to Induction Therapy in Patients with Acute Myeloid Leukemia

Blood, 2014-12, Vol.124 (21), p.3686-3686

2014

Volltextzugriff (PDF)

Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma- Retrospective Analysis of 2 Randomized Trials of the German Low Grade Lymphoma Study Group (GLSG)

Blood, 2016-12, Vol.128 (22), p.3464-3464

2016

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(105)

Publikationsform

Sprache

Englisch
(107)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(48)
Life Sciences & Biomedicine
(40)
Science & Technology
(40)
Female
(39)
Male
(37)
Middle Aged
(36)
Adult
(30)
Hematology
(27)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Aged
(23)
Hematologic And Hematopoietic Diseases
(17)
Adolescent
(16)
Disease-Free Survival
(16)
Treatment Outcome
(15)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(14)
Oncology
(12)
Aged, 80 And Over
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Leukemia, Myeloid, Acute - Genetics
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial

Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study

Long-Term Prognosis of Acute Myeloid Leukemia According to the New Genetic Risk Classification of the European LeukemiaNet Recommendations: Evaluation of the Proposed Reporting System

Prophylactic Platelet Transfusion

WHO classification of myeloid neoplasms and leukemia

Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Hematologic Malignancies After Dose-Escalated Treosulfan/Fludarabine Conditioning

Phase III Trial of High-Dose Sequential Chemotherapy With Peripheral Blood Stem Cell Support Compared With Standard Dose Chemotherapy for First-Line Treatment of Advanced Ovarian Cancer: Intergroup Trial of the AGO-Ovar/AIO and EBMT

In Reply

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

Platelet Transfusion in Hematology, Oncology and Surgery

Cytarabine Dose of 36 g/m2 Compared With 12 g/m2 Within First Consolidation in Acute Myeloid Leukemia: Results of Patients Enrolled Onto the Prospective Randomized AML96 Study

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Therapeutic platelet transfusion for hypoproliferative thrombocytopenia – Authors' reply

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Platelet transfusion in hematology, oncology and surgery

A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)

Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trial

Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group

Consolidation Therapy Is Associated with Significantly Lower Bleeding Risk Compared to Induction Therapy in Patients with Acute Myeloid Leukemia

Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma- Retrospective Analysis of 2 Randomized Trials of the German Low Grade Lymphoma Study Group (GLSG)

Suchergebnisse filtern